Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ab-vancomycin
2. Diatracin
3. Hydrochloride, Vancomycin
4. Sulfate, Vancomycin
5. Vanco Azupharma
6. Vanco-cell
7. Vanco-saar
8. Vancocin
9. Vancocin Hcl
10. Vancocine
11. Vancomicina Abbott
12. Vancomicina Chiesi
13. Vancomicina Combino Phar
14. Vancomicina Norman
15. Vancomycin
16. Vancomycin Hexal
17. Vancomycin Hydrochloride
18. Vancomycin Lilly
19. Vancomycin Phosphate (1:2)
20. Vancomycin Phosphate (1:2), Decahydrate
21. Vancomycin Sulfate
22. Vancomycin-ratiopharm
23. Vancomycine Dakota
1. Vancomycin Hydrochloride
2. Vancocin Hcl
3. 1404-93-9
4. Vancomycin Hydrochloride (extracted From Streptomyces Orientalis)
| Molecular Weight | 1485.7 g/mol |
|---|---|
| Molecular Formula | C66H76Cl3N9O24 |
| Hydrogen Bond Donor Count | 20 |
| Hydrogen Bond Acceptor Count | 26 |
| Rotatable Bond Count | 13 |
| Exact Mass | 1483.406877 g/mol |
| Monoisotopic Mass | 1483.406877 g/mol |
| Topological Polar Surface Area | 531 Ų |
| Heavy Atom Count | 102 |
| Formal Charge | 0 |
| Complexity | 2960 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 17 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Vancocin hydrochloride |
| Active Ingredient | Vancomycin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | eq 125mg base; eq 250mg base |
| Market Status | Prescription |
| Company | Ani Pharms |
| 2 of 4 | |
|---|---|
| Drug Name | Vancomycin hydrochloride |
| Active Ingredient | Vancomycin hydrochloride |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | eq 750mg base/vial; eq 125mg base; eq 250mg base; eq 5gm base/vial; eq 500mg base/vial; eq 10gm base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Hospira; Sandoz; Watson Labs; Strides Pharma; Emcure Pharms; Mustafa Nevzat Ilac; Fresenius Kabi Usa; Sagent Pharms; Agila Speclts; Akorn |
| 3 of 4 | |
|---|---|
| Drug Name | Vancocin hydrochloride |
| Active Ingredient | Vancomycin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | eq 125mg base; eq 250mg base |
| Market Status | Prescription |
| Company | Ani Pharms |
| 4 of 4 | |
|---|---|
| Drug Name | Vancomycin hydrochloride |
| Active Ingredient | Vancomycin hydrochloride |
| Dosage Form | Capsule; Injectable |
| Route | Injection; Oral |
| Strength | eq 750mg base/vial; eq 125mg base; eq 250mg base; eq 5gm base/vial; eq 500mg base/vial; eq 10gm base/vial; eq 1gm base/vial |
| Market Status | Prescription |
| Company | Hospira; Sandoz; Watson Labs; Strides Pharma; Emcure Pharms; Mustafa Nevzat Ilac; Fresenius Kabi Usa; Sagent Pharms; Agila Speclts; Akorn |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - POWDER;INTRAVENOUS - EQ 1.25GM BASE/...DOSAGE - POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 1.5GM BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 1.75GM BASE/...DOSAGE - POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 2GM BASE/VIA...DOSAGE - POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS - EQ 750MG BASE/V...DOSAGE - POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL
USFDA APPLICATION NUMBER - 209481
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.25GM...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.25GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.5MG ...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1.5MG BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 10GM B...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1GM BA...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 500MG ...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 5GM BA...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 750MG ...DOSAGE - POWDER;INTRAVENOUS, ORAL - EQ 750MG BASE/VIAL
USFDA APPLICATION NUMBER - 210274
DOSAGE - CAPSULE;ORAL - EQ 125MG BASE
USFDA APPLICATION NUMBER - 50606
DOSAGE - CAPSULE;ORAL - EQ 250MG BASE
USFDA APPLICATION NUMBER - 50606
Related Excipient Companies
Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Empty Capsules
Coating Systems & Additives
Parenteral
Film Formers & Plasticizers
Solubilizers
Controlled & Modified Release
Thickeners and Stabilizers
Granulation
Lubricants & Glidants
Taste Masking
Fillers, Diluents & Binders
Co-Processed Excipients
Direct Compression
Surfactant & Foaming Agents
Emulsifying Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
87
PharmaCompass offers a list of Vancomycin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vancomycin Hydrochloride manufacturer or Vancomycin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vancomycin Hydrochloride manufacturer or Vancomycin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Vancomycin Hydrochloride API Price utilized in the formulation of products. Vancomycin Hydrochloride API Price is not always fixed or binding as the Vancomycin Hydrochloride Price is obtained through a variety of data sources. The Vancomycin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vancocin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vancocin Hydrochloride, including repackagers and relabelers. The FDA regulates Vancocin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vancocin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vancocin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vancocin Hydrochloride supplier is an individual or a company that provides Vancocin Hydrochloride active pharmaceutical ingredient (API) or Vancocin Hydrochloride finished formulations upon request. The Vancocin Hydrochloride suppliers may include Vancocin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Vancocin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vancocin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Vancocin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Vancocin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Vancocin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vancocin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Vancocin Hydrochloride USDMF includes data on Vancocin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vancocin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vancocin Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Vancocin Hydrochloride Drug Master File in Japan (Vancocin Hydrochloride JDMF) empowers Vancocin Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Vancocin Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Vancocin Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Vancocin Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vancocin Hydrochloride Drug Master File in Korea (Vancocin Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vancocin Hydrochloride. The MFDS reviews the Vancocin Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Vancocin Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vancocin Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vancocin Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vancocin Hydrochloride suppliers with KDMF on PharmaCompass.
A Vancocin Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Vancocin Hydrochloride Certificate of Suitability (COS). The purpose of a Vancocin Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vancocin Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vancocin Hydrochloride to their clients by showing that a Vancocin Hydrochloride CEP has been issued for it. The manufacturer submits a Vancocin Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vancocin Hydrochloride CEP holder for the record. Additionally, the data presented in the Vancocin Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vancocin Hydrochloride DMF.
A Vancocin Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vancocin Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vancocin Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Vancocin Hydrochloride written confirmation (Vancocin Hydrochloride WC) is an official document issued by a regulatory agency to a Vancocin Hydrochloride manufacturer, verifying that the manufacturing facility of a Vancocin Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vancocin Hydrochloride APIs or Vancocin Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Vancocin Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Vancocin Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vancocin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vancocin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vancocin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vancocin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vancocin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vancocin Hydrochloride suppliers with NDC on PharmaCompass.
Vancocin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vancocin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vancocin Hydrochloride GMP manufacturer or Vancocin Hydrochloride GMP API supplier for your needs.
A Vancocin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Vancocin Hydrochloride's compliance with Vancocin Hydrochloride specifications and serves as a tool for batch-level quality control.
Vancocin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Vancocin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vancocin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Vancocin Hydrochloride EP), Vancocin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vancocin Hydrochloride USP).
